Clinical-stage biotech developer CNS Pharmaceuticals is working to demonstrate the potential effectiveness of its novel drug, Berubicin, in treating aggressive and rare brain cancer glioblastoma multiforme (“GBM”) CNS expects to launch Phase II trials of Berubicin later this year or in Q1 of 2021, building on promising results shown in initial trials One patient in […]

Pharmaceutical services innovator Trxade Group Inc. has gained investor attention as it has emerged as a responsive healthcare market force during the ongoing COVID-19 pandemic As the pandemic began to unfold earlier this year, Trxade Group saw revenues jump effectively to three times their previous Q1 level, largely as a result of personal protective equipment […]

SGMD has filed updated Form 8K Current Report with SEC Filing includes information about issues related to company’s status, including planned expansion of BudCars cannabis-delivery service Sugarmade sees “major business opportunities out of both sites once operations begin” Sugarmade (OTCQB: SGMD), a product and branding marketing company investing in operations and technologies with disruptive potential, […]

Rritual’s suite of premium functional mushroom and adaptogenic elixirs is designed to offer various health benefits, such as increased immunity, cognitive function, stress management and more The company’s products are expected to be available online through Rritual’s site and Amazon by fall 2020 The Rritual team has extensive ties and influential relationships with leading retail […]

Research shows psilocybin produces immediate, substantial and sustained improvements in anxiety and depression Global medicinal mushroom market projected to increase by almost $14 billion annually for the next several years Pure Extracts is a plant-based extraction company with new vertical in the mushroom space Recent groundbreaking research indicates that psilocybin-assisted psychotherapy may be effective in […]

VistaGen’s product portfolio consists of three novel drug candidates that, together, target multiple anxiety disorders, depression disorders and neurological disorders Two of the company’s drug candidates have received an FDA fast track designation, including for the treatment of social anxiety disorder, major depressive disorder and neuropathic pain. The global CNS therapeutics market is estimated to […]

The company’s current independent pharmacy member base represents over 50% of the United States pharmaceutical market within that vertical Actively used in all 50 states with over 11,700 pharmacies in its network, serving around 15 million patients indirectly through these networks of pharmacies Pharmaceutical supplies and services provider Trxade Group (NASDAQ: MEDS) benefited from an […]

Actively executing its growth-by-acquisition strategy, building a portfolio of clinically proven, naturally formulated supplements The BergaMet NA brand is well-positioned for growth throughout North America with its proprietary 47% BPF formulations developed for cardiovascular health, women’s health, immune support, sports performance and recovery UBN subsidiary, with its KETONOMICS(R) proprietary formulation, is well-aligned with Grey Cloak’s […]

PACR bought nine parcels comprising 250 acres of land in Fraser Valley, British Columbia Share purchase agreement worth $1.5 million cash plus 3 million common shares PACR leverages genetic technology to produce high-yield cannabinoid-specific cultivars that thrive in B.C. climate Pac Roots Cannabis (CSE: PACR), an innovative genetics-based cannabis company based in Canada, has just […]

BudCars CEO featured guest during “Cannabis Talk 101” show SGMD partnership allowed company to “focus on growth” Walker recognizes Sugarmade’s great accounting, management team The history and future of BudCars Cannabis Delivery Service was spotlighted during a recent “Cannabis Talk 101” episode. BudCars founder and CEO Clinton Walker was a featured guest on the global […]